Business
Novo's Wegovy Pill Shows Promise in Real-World Study
A real-world study on Novo's Wegovy pill indicates that patients may be able to switch from weekly injections to more convenient treatments, potentially improving adherence and outcomes.
Coverage timeline — 1 article
CNBC
The data on Novo's Wegovy pill suggests that patients may not need to take weekly injections forever, but can instead opt for more convenient treatments.
2026-09-30 09:45 UTC